Oxford says AstraZeneca trials in US, Chile, Peru shows COVID vaccine safe

Phase three trials involving more than 32,000 volunteers across all age groups, conducted in the US, Chile and Peru have shown that COVID-19 AstraZeneca vaccine is safe and highly effective, the University of Oxford said on Monday.

>>Reuters
Published : 22 March 2021, 07:39 AM
Updated : 22 March 2021, 07:39 AM

"These results are great news as they show the remarkable efficacy of the vaccine in a new population and are consistent with the results from Oxford-led trials," Andrew Pollard, who runs the Oxford Vaccine Group, said.